Shamar Young, MD

Associate professor and Chief of Interventional Radiology
University of Arizona

Presentation(s):

• Career advancement in early career: my experiences and challenges I faced

  Saturday, March 4, 2023
  3:00 PM – 3:10 PM

  Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)

• Dosimetry: The next frontier

  Sunday, March 5, 2023
  8:30 AM – 10:00 AM

  Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)

• Normal tissue dosing, a waist of time or integral treatment tool

  Sunday, March 5, 2023
  8:30 AM – 8:43 AM

  Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)

• Dosimetry in HCC: What do we know, what can we still learn

  Sunday, March 5, 2023
  8:56 AM – 9:09 AM

  Disclosure information not submitted.

• Deep venous thrombosis interventions: Change over time and relative percentage performed by Interventional Radiologists.

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)

• Simplicity

  Monday, March 6, 2023
  1:00 PM – 1:20 PM

  Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)

• Transarterial radioembolization of intrahepatic cholangiocarcinoma: A dose threshold study.

  Monday, March 6, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Galvanize Therapeutics: Consultant (Ongoing); Histosonics Inc: Consultant (Terminated); Mirada: Consultant (Ongoing); Varian: Consultant (Ongoing)